Philip D. Coblentz

Pharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure.

L. Ferreira, P. Adhihetty, A. Smuder, 2016, Journal of applied physiology.

Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation

Adam W. Beharry, L. Ferreira, A. Judge, 2017, Front. Physiol..

Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.

L. Ferreira, L. Hayward, B. Ahn, 2019, American journal of physiology. Lung cellular and molecular physiology.